
A U.S. Food and Drug Administration advisory panel voted Tuesday to recommend emergency use of a smaller dose of Pfizer’s coronavirus vaccine for children aged 5 to 11, advancing plans to offer the shots to 28 million young kids across the United States. The vote was nearly unanimous at 17-0, with one abstention, and the… read on > read on >